New heart valve fix could spare patients from major surgery

NCT ID NCT06038838

Recruiting now Disease control Sponsor: Tioga Cardiovascular, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 12, 2025 · Last updated May 15, 2026 · Updated 22 times

Summary

This study tests a new device called the Tioga TMVR System to treat a leaky heart valve (mitral regurgitation) without open-heart surgery. It involves 30 adults with moderate-to-severe symptoms who are not good candidates for surgery. The goal is to see if the device is safe and can be placed correctly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Helsicore Hospital (Israeli Georgeian Medical Research Clinic Healthycore)
RECRUITING

Tbilisi, Georgia

Contact Email: •••••@•••••
Incor - Instituto do Coração do Hospital das Clínicas da FMUSP
RECRUITING

São Paulo, Brazil

Contact Email: •••••@•••••
Sanatorio Italiano
RECRUITING

Asunción, Paraguay

Contact Phone: •••-•••-••••
Tbilisi Heart and Vascular Clinic
RECRUITING

Tbilisi, Georgia

Contact Email: •••••@•••••
Vilnius Univ. Hospital
RECRUITING

Vilnius, Lithuania

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MITRAL REGURGITATION